Acdal, Teofilo R.
HRN: 24-23-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/15/2023
12/21/2023
IV
2.25gm
Q6
Septicemia Renal Adjustment
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes